Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Investor Relations
  3. Press releases, Ad-hocs & Related Party Transactions
Investor relations

Press releases, Ad-hocs & Related Party Transactions

3min

Latest press releases

ARPA-H Awards Siemens Healthineers up to $83 Million, Including a $23 Million Cost Share, to Advance Photon Flash Radiotherapy for Cancer Care
Palo Alto, CA, USA
ARPA-H Awards Siemens Healthineers up to $83 Million, Including a $23 Million Cost Share, to Advance Photon Flash Radiotherapy for Cancer Care.

FAST III Study Validates Less-Invasive Method for Coronary Revascularization Guidance as Safe and Effective Alternative
Forchheim, Germany
Today the results of the FAST III study, co-funded by Siemens Healthineers and Pie Medical Imaging, were presented. The results confirm the safety and efficacy of Caas vFFR an alternative to conventional pressure wire-based physiology for guiding revascularization strategy in patients with intermediate coronary artery stenosis.

Ad-hoc announcements & Related Party Transactions

Here you will find all ad hoc announcements (disclosure of inside information according to Article 17 of Regulation (EU) No 596/2014 on market abuse) and announcements of material transactions with related parties in accordance with section 111c of the German Stock Corporation Act of Siemens Healthineers AG.